Not all individuals with CLL call for therapy. Despite all current advancements, the iwCLL even now suggests watchful observation for clients with asymptomatic sickness.86 This advice is based on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials https://briann420hqx7.wikifiltraciones.com/user